This study demonstrated that genetically engineered T cells expressing MAGE-A4-specific TCR could prevent the growth of esophageal cancer expressed MAGE-A4 in immunodeficient NOG mice (Shirakura et al. 2012). This evidence concerns the gene MAGEA4 and esophageal cancer.